BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bessissow T, Nguyen GC, Tarabain O, Peyrin-Biroulet L, Foucault N, McHugh K, Ruel J. Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study. World J Gastroenterol 2022; 28(34): 5058-5075 [PMID: 36160646 DOI: 10.3748/wjg.v28.i34.5058]
URL: https://www.wjgnet.com/1007-9327/full/v28/i34/5058.htm
Number Citing Articles
1
Meng Wang, Yanhong Sun, Yonghu Sun. Efficacy and safety of drugs for psoriasis patients with mental disorders: A systematic reviewJournal of Affective Disorders 2024; 365: 112 doi: 10.1016/j.jad.2024.08.077
2
Michael Youssef, Nariman Hossein-Javaheri, Tedi Hoxha, Christina Mallouk, Parul Tandon. Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysisJournal of Crohn's and Colitis 2024; 18(9): 1486 doi: 10.1093/ecco-jcc/jjae057
3
Christy Riggott, Alexander C. Ford, David J. Gracie. Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implicationsAlimentary Pharmacology & Therapeutics 2024; 60(9): 1200 doi: 10.1111/apt.18192
4
AdalimumabReactions Weekly 2023; 1952(1): 28 doi: 10.1007/s40278-023-37121-1
5
Masahiro Iizuka, Takeshi Etou, Haruka Yorozu, Bunichiro Kato, Takeya Edagawa, Shiho Sagara, Hiro-O Matsushita, Kenjiro Yoshikawa. Efficacy of Biologics in Patients with Ulcerative Colitis Exhibiting Non-Response or Insufficient Response to CytapheresisJournal of Clinical Medicine 2025; 14(18): 6574 doi: 10.3390/jcm14186574
6
Christy Riggott, Keeley M. Fairbrass, Elspeth A. Guthrie, Christopher J. Black, Christian P. Selinger, Alexander C. Ford, David J. Gracie. Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up StudyAlimentary Pharmacology & Therapeutics 2025;  doi: 10.1111/apt.70431